Description
Maps
SDGs
Select Year Range:

3.b.2 Gross Disbursements of Official Development Assistance for Medical Research and Basic Health Sectors (by recipient)

Target 3.b: Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all

Goal 3: Ensure healthy lives and promote well-being for all at all ages

Custodian Organization: Organisation for Economic Co-operation and Development (OECD)

Tier Classification: Tier I

To facilitate the implementation of the global indicator framework, all indicators are classified by the IAEG-SDGs (Inter-Agency and Expert Group on Sustainable Development Goals Indicators) into three tiers on the basis of their level of methodological development and the availability of data at the global level, as follows:

Tier I: Indicator is conceptually clear, has an internationally established methodology and standards are available, and data are regularly produced by countries for at least 50 per cent of countries and of the population in every region where the indicator is relevant.

Tier II: Indicator is conceptually clear, has an internationally established methodology and standards are available, but data are not regularly produced by countries.

Tier III: No internationally established methodology or standards are yet available for the indicator, but methodology/standards are being (or will be) developed or tested.

Source: United Nations Statistical Division

Definition: Gross disbursements of total official development assistance (ODA) from all donors to medical research and basic health sectors.

Concepts: ODA: The OECD Development Assistance Committee (DAC) defines ODA as “those flows to countries and territories on the DAC List of ODA Recipients and to multilateral institutions which are i) provided by official agencies, including state and local governments, or by their executive agencies; and ii) each transaction is administered with the promotion of the economic development and welfare of developing countries as its main objective; and is concessional in character and conveys a grant element of at least 25 per cent (calculated at a rate of discount of 10 per cent). (See http://www.oecd.org/dac/stats/officialdevelopmentassistancedefinitionandcoverage.htm)

Medical research and basic health sectors are as defined by the DAC. Medical research refers to CRS sector code 12182 and basic health covers all codes in the 122 series (see here)

Rationale: Total ODA flows to developing countries quantify the public effort that donors provide to developing countries for medical research and basic health.

Limitations: Data in the Creditor Reporting System are available from 1973. However, the data coverage is considered complete from 1995 for commitments at an activity level and 2002 for disbursements.

Source: United Nations Statistical Division

Data Source: Data for this indicator was primarily collected from the United Nations Statistics Division’s Open SDG Data Hub. National level data from the UN Statistics Division is compiled by the respective custodian for the SDG indicator, unless otherwise noted. To learn more about the data used in this portal, visit the about page.

Data is accurate as of October 31, 2018

3.b.2 Gross Disbursements of Official Development Assistance for Medical Research and Basic Health Sectors (by recipient)

 
Loading

3.b.2 Gross Disbursements of Official Development Assistance for Medical Research and Basic Health Sectors (by recipient) Sustainable Development Goals

3. Ensure healthy lives and promote well-being for all at all ages
3. Ensure healthy lives and promote well-being for all at all ages

3. Ensure healthy lives and promote well-being for all at all ages

Ensuring healthy lives and promoting the well-being for all at all ages is essential to sustainable development. Significant strides have been made in increasing life expectancy and reducing some of the common killers associated with child and maternal mortality. Major progress has been made on increasing access to clean water and sanitation, reducing malaria, tuberculosis, polio and the spread of HIV/AIDS. However, many more efforts are needed to fully eradicate a wide range of diseases and address many different persistent and emerging health issues.

Related 3.b.2 Gross Disbursements of Official Development Assistance for Medical Research and Basic Health Sectors (by recipient) Targets

3.b
Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all